Add Yahoo as a preferred source to see more of our stories on Google. Anemia is the most prevalent blood condition in the U.S. Annually, the condition accounts for 2.8 million visits to physician ...
What Is Omisirge, and Why Does It Matter? Omisirge (omidubicel-onlv) is a type of cell therapy made from umbilical cord blood. It helps your body make new blood cells after a stem cell transplant.
Severe aplastic anemia used to have few options and mortality was high, but a new class of drugs offers some hope. A recent review examined treatment options for aplastic anemia (AA), a hematopoietic ...
The (ASH) released guidelines on the diagnosis and management of severe acquired aplastic anemia, a rare and ...
The American Society of Hematology (ASH) released guidelines on the diagnosis and management of severe acquired aplastic ...
A single-group, phase 1–2 study indicated that eltrombopag improved the efficacy of standard immunosuppressive therapy that entailed horse antithymocyte globulin (ATG) plus cyclosporine in patients ...
Eltrombopag combined with immunosuppressive therapy in pediatric patients with severe aplastic anemia achieved a 54.9% overall response rate at 26 weeks, with a 71.4% response in relapsed/refractory ...
At Fred Hutchinson Cancer Center, we surround you with experts who focus completely on aplastic anemia, day in and day out. A handful of people form the core of your care team. You have an physician ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results